code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primare care clinics
No description available
No description available
No description available
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
No description available
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer’s, and seizure dogs for refractory epilepsy.
No description available
No description available
No description available
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing benefits of DBS for traumatic brain injury; adaptive functioning in children exposed in utero to antiseizure drugs, and the best advances of 2023.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson’s patients; underrepresentation of non-White people in Alzheimer’s trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson;s.
No description available
No description available
No description available
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson’s disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.
No description available
No description available
No description available